INSIDER · CIK 1595117
George Simeon
Director at CRISPR Therapeutics AG (CRSP) · Director, 10% Owner at ADARx Pharmaceuticals, Inc. (ADRX)
↗4 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$27.2MBought on the market
$720KSold on the market
2Companies
Oct 16, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202617:45 | Oct 14, 2026 | CRSPCRISPR Therapeutics AG | Director | S · Sell10b5-1 | $49.63 | −14,514 | 15,486 | -48% | −$720K | ||
| Oct 16, 202617:45 | Oct 14, 2026 | CRSPCRISPR Therapeutics AG | Director | M · Exercise10b5-1 | $14.00 | +30,000 | 30,000 | New | $420K | ||
| Sep 29, 202621:43 | Sep 28, 2026 | ADRXADARx Pharmaceuticals, Inc. | Director, 10% Owner | P · Buy | $17.00 | +1,600,000 | 592,593 | — | +$27.2M | -12.1% | +5.6% |
| Sep 29, 202621:43 | Sep 28, 2026 | ADRXADARx Pharmaceuticals, Inc. | Director, 10% Owner | C · Convert | — | +8,336,661 | 1,836,469 | — | — |